Kritika Agarwal, Associate Partner – Corporate/M&A and Competition spoke to The Hindu Business Line on Indemnity for vaccine makers. According to her, “vaccine manufacturers may not want to spend time and money on defending any claims in all the countries where they supply and be subject to extensive litigation.”
Read the full article here.